Although millions of new drugs, innovative medical technologies and delivery systems are discovered every year, they simply wouldn't function successfully without vast initial investment into research and development (R&D). During the past year alone, the UK's medical funding body, the Medical Research Council, recorded a gross research expenditure of ￡814 million, which was up from the ￡755.5 million in the previous year. And this significant investment is entirely understandable given the pivotal role that R&D plays in contributing to the drug discoveries that transform the treatment of millions of patients.
展开▼
